Rowen S
Mercy Medical Center, Baltimore, MD 21202, USA.
Curr Opin Ophthalmol. 1999 Feb;10(1):29-35. doi: 10.1097/00055735-199902000-00006.
The current state of cataract surgery for the millennium may be stated as "minimally invasive techniques." This review presents recent articles on the perioperative use of antibiotics (primarily fluoroquinolones), nonsteroidal antiinflammatory drugs (Voltaren and ketorolac), and new corticosteroids (rimexolone and loteprednol etabonate). Preoperative topical application of ofloxacin or ciprofloxacin results in a satisfactory minimal inhibitory concentration for most pathogens. However, one cannot determine the actual effect of intraoperative antibiotics on acute postoperative endophthalmitis, because of its low overall incidence. Nonsteroidal antiinflammatory drugs, especially Voltaren, may offer equivalent antiinflammatory efficacy (for both postoperative inflammation and cystoid macular edema) without the typically corticosteroid-associated adverse events. Rimexolone and loteprednol etabonate, two new corticosteroids, may offer good antiinflammatory efficacy with greatly reduced risk for elevation of intraocular pressure.
千禧年白内障手术的当前状态可表述为“微创技术”。本综述介绍了近期关于围手术期使用抗生素(主要是氟喹诺酮类)、非甾体抗炎药(扶他林和酮咯酸)以及新型皮质类固醇(利美索龙和氯替泼诺)的文章。术前局部应用氧氟沙星或环丙沙星对大多数病原体可产生令人满意的最低抑菌浓度。然而,由于术中抗生素对急性术后眼内炎的总体发生率较低,因此无法确定其实际效果。非甾体抗炎药,尤其是扶他林,可能具有同等的抗炎功效(对术后炎症和黄斑囊样水肿均有效),且无典型的皮质类固醇相关不良事件。两种新型皮质类固醇利美索龙和氯替泼诺,可能具有良好的抗炎功效,同时显著降低眼压升高的风险。